SP
Highly rated in
8
conditions
Highly rated in
8
conditions
Check Dr. Sabrina Paganoni's experience treating your condition:
About Dr. Sabrina Paganoni

Sabrina Paganoni is a Physiatrist in Boston, Massachusetts. Paganoni has been practicing medicine for over 23 years and is highly rated in 8 conditions, according to our data. Her top areas of expertise are Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis ALS or Lou Gehrig's Disease, Spinal Muscular Atrophy Type 3, and Spinal and Bulbar Muscular Atrophy. She is licensed to treat patients in Massachusetts. Paganoni is currently accepting new patients.

Her clinical research consists of co-authoring 112 peer reviewed articles and participating in 9 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Sabrina Paganoni it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Sabrina Paganoni accepts the following insurance:

  •  Ambetter
  •  Anthem

Call to see if your plan is accepted.
Locations
165 Cambridge St, Suite 820, Boston, MA 02114
Other Locations
15 Parkman St, Soom 835, Boston, MA 02114
Background & Education
Graduate Institution
Other, 1999
Specialties
Physiatry
Licenses
Neuromuscular Medicine in MA
Hospital Affiliations
Spaulding Rehabilitation Hospital Cape Cod
Brigham And Womens Hospital
Massachusetts General Hospital
Spaulding Hospital For Continuing Medical Care Cambridge
Boston Medical Center
Spaulding Rehabilitation Hospital Boston
Beth Israel Deaconess Hospital - Plymouth
Languages Spoken
English
Italian
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


9 Clinical Trials

A Pilot Study of RNS60 in Amyotrophic Lateral Sclerosis (ALS)
Phase 2a Study of the Expansion and Infusion of Autologous T-Regulatory Cells in Amyotrophic Lateral Sclerosis
A Pilot Study of Inosine in Amyotrophic Lateral Sclerosis (ALS)
A Phase 2 Pharmacodynamic Trial of Ezogabine (Retigabine) on Neuronal Excitability in Amyotrophic Lateral Sclerosis
A Multi-Center, Open-Label Biomarker Study to Evaluate MN-166 (Ibudilast) in Subjects With Amyotrophic Literal Sclerosis (ALS)
A Multicenter, 18-week Open Label Safety and Efficacy Trial of Dalfampridine in Primary Lateral Sclerosis
Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS)
Evaluation of the Safety, Tolerability, Efficacy and Activity of AMX0035, a Fixed Combination of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA), for the Treatment of ALS
View 8 Less Clinical Trials -

112 Total Publications

Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors